Problem: Fine needles used in biopsies are kind to the patient but are difficult to see under ultrasound: Nearly one in five must be repeated, often under costly CT or MRI procedures, and untold numbers of diagnoses are missed altogether. Competitors’ “solutions”, such as cutting notches in the needles, are not effective. The problem is both serious and large: some five million procedures are conducted each year.
NuVue Solution: NuVue will revolutionize fine needle aspiration (FNA) biopsies with its NuVue ColorMark™- A needles.
These disposable, single-use needle devices use the Company’s enhanced ultrasound guided visualization (UGV) technology to make the needle visible to a color Doppler ultrasound imaging system, creating a remarkably clear and bright image on the screen, in real time, all the time, during clinical procedures.
The NuVue CorlorMarkTM–A needles are ready to go to market:
• Reimbursement codes are already in place.
• FDA “510(k)” approval is in place.
• Design is complete and manufacturing facilities are in place.
NuVue foresees rapid adoption of the ColorMarkTM-A&C Needles because they improve current methods, without changing current procedures. Practitioners continue what they are doing now – we simply make them more effective.
With their improved accuracy and safety, NuVue’s ColorMark™-A needles can aid in early, accurate diagnosis of soft tissue cancers.
For further information or to pre-order ColorMark™-A fine needle aspiration biopsy needles, please contact us.
|
